Compare

Ardelyx, Inc. vs Arrowhead Pharmaceuticals, Inc. vs Zai Lab Ltd vs MannKind Corp

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearArdelyx, Inc.
ARDX
Arrowhead Pharmaceuticals, Inc.
ARWR
Zai Lab Ltd
ZLAB
MannKind Corp
MNKD
Year ended2025-12-312026-09-302025-12-312025-12-31
Revenue$407.32M$450.82M$457.18M$348.97M
Revenue growth (YoY)+22.1%-45.6%+15.0%+22.2%
Gross margin90.3% (computed)n/a58.3% (computed)92.3% (computed)
Operating margin-10.1%-156.9%-50.2%11.1%
Net margin-15.1%-159.1%-38.4%1.7%
Net income-$61.60M-$717.13M-$175.54M$5.86M
EPS (Diluted)-$0.26-$5.11-$0.16$0.02
Operating cash flow-$42.48M-$271.95M-$150.79M$18.25M
Free cash flow-$43.98M-$283.94M-$158.89M$13.69M
Cash & equivalents$68.00Mn/a$679.57M$74.88M
Total assets$501.60M$1.74B$1.17B$792.18M
Total liabilities$334.65Mn/a$456.88M$843.20M
Shareholders' equity$166.95M$50.50M$715.50M-$51.02M
Return on year-end equity-36.9%n/m-24.5%n/a
Shares outstanding244.35M141.29M1.11B307.83M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearArdelyx, Inc.Arrowhead Pharmaceuticals, Inc.Zai Lab LtdMannKind Corp
Latest$407.32M
Ended 2025-12-31
$450.82M
Ended 2026-09-30
$457.18M
Ended 2025-12-31
$348.97M
Ended 2025-12-31
1 year earlier$333.62M
Ended 2024-12-31
$829.45M
Ended 2025-09-30
$397.61M
Ended 2024-12-31
$285.50M
Ended 2024-12-31
2 years earlier$124.46M
Ended 2023-12-31
$3.55M
Ended 2024-09-30
$266.72M
Ended 2023-12-31
$198.96M
Ended 2023-12-31
3 years earlier$52.16M
Ended 2022-12-31
$240.74M
Ended 2023-09-30
$212.67M
Ended 2022-12-31
$99.77M
Ended 2022-12-31
4 years earlier$10.10M
Ended 2021-12-31
$243.23M
Ended 2022-09-30
$144.10M
Ended 2021-12-31
$75.44M
Ended 2021-12-31